Bedside bone biopsy for diabetic foot infection
Part of Heart & circulation, Hormones & metabolism, Skin clinical trials.
This trial is testing a new way to take a small sample of infected bone from the foot of people with diabetes. It aims to see if a bedside biopsy is safe and accurate for diagnosing bone infection, so you may avoid more invasive procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have diabetes
- You have a foot wound that reaches bone, or an X-ray or scan shows bone infection
- You have not taken any antibiotics in the last 14 days
- You do not need immediate foot surgery and your leg blood flow is not severely blocked
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what affects changes in quality of life in people with diabetes who have a long-term, wound-free Charcot foot. It may help doctors understand what matters most for day-to-day wellbeing in this condition.
This study is looking for people with diabetes who have an open foot or ankle ulcer. Researchers want to collect samples to find biomarkers, which are natural signs in the body that could help improve treatment and healing. It may be a good fit if you have a diabetic foot ulcer and are not currently in another drug trial for ulcers.
This study uses a special imaging scan (PET/CT) to see if a foot infection has spread to the bone in people with diabetes. The scan may help doctors diagnose bone infection more accurately, potentially avoiding unnecessary treatments.
This study tests a new device that quickly identifies the germs in foot wounds of people with diabetes and bone infections. It may help doctors choose the right antibiotic faster.
This study aims to find out which bacteria are causing your diabetic foot infection by testing a small sample from your wound. This could help doctors choose better treatments for you and others with similar infections.
This trial tests a special glass material (bioactive glass S53P4) placed into the bone after surgery to treat a diabetic foot infection in the forefoot. It may help heal the infection better than standard care.
Hear when a new Subjects With Diabetes and DFU With a Suspicion of DFO trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.